Deborah Sherman and Nicole Vap 9News.com Tue, 27 Nov 2007 00:02 UTC
KUSA - It's all caught on tape: children strapped down in dental chairs, parents not allowed to watch and dentists competing for bonuses for doing the most work on their smallest patients.
Washington, D.C., has the highest rate of AIDS in the United States, and more babies are born with the AIDS virus in Washington than in other U.S. cities, according to a report released on Monday.
WASHINGTON - Too little milk, sunshine and exercise: It's an anti-bone trifecta. And for some kids, shockingly, it's leading to rickets, the soft-bone scourge of the 19th century.
PROVIDENCE, R.I. - Rhode Island Hospital was fined $50,000 and reprimanded by the state Department of Health Monday after its third instance this year of a doctor performing brain surgery in the wrong side of a patient's head.
Viewing the reflected image of an intact limb in a mirror can fool the mind into thinking that a lost leg or foot still exists, dramatically relieving phantom limb pain, researchers reported on Wednesday.
At least 9 out of 10 amputees report feeling sometimes-severe pain in the missing limb, often the result of a sensation that the arm or leg is stuck in the wrong position. The sensation can be excruciating and pain drugs often do little to help.
But some studies have suggested that using a mirror to trick the mind into thinking the lost limb is still there may help. Doctors do not understand why it works, but it appears to help a confused brain reconcile sensations coming from the severed nerves.
Jacque Hillman Jackson Sun Mon, 26 Nov 2007 14:13 UTC
Yates, 7, loves chewing gum. He'll go through every compartment in a purse looking for it intently. He doesn't give up unless he's distracted with something else.
He loves to flush the toilet, and once he put tennis balls down the toilet so it overflowed and he could watch the water run. He's also shut the bathtub drain and turned the water on.
Can the pharmaceutical industry be trusted to fund doctors' compulsory education without introducing bias? The issue is dividing Congress, academics and drugs companies. Now, preliminary data have emerged suggesting that industry-sponsored courses skew training material in favour of commercial interests.
Sussane Rust, Meg Kissinger and Cary Spivak Journal Sentinel Sat, 24 Nov 2007 22:35 UTC
Take a look at your shoes, your shampoo, your carpet, your baby's bottles, even the dental sealants in your mouth. These products contain chemicals that disrupt the natural way hormones work inside of you.
The chemicals known as endocrine disruptors are all over your house, your clothing, your car. The chemicals are even in you.
They promise to make skin softer, clothes smell fresher and food keep longer. The problem is, neither the companies that make these products nor federal regulators are telling you that some of these substances may be dangerous. Many have been found to cause life-threatening illnesses in laboratory animals.
Stimulating the brain with rapid bursts of magnetic energy is a safe and effectively treatment for major depression, a new large-scale study has found.
The finding offers a ray of hope to the 20 to 40 percent of patients who do not respond to antidepressants and psychotherapy and to those who do not wish to treat their illness with drugs.
"This study provides new support for the efficacy of TMS (transcranial magnetic stimulation) as a 'stand alone' treatment for depression," said John Krystal, editor of Biological Psychiatry which will publish the study on December 1.
"This finding could be particularly important for patients who do not tolerate antidepressant medications, for whom they are not safe, or who have not benefited from other alternative treatments."
The role of melatonin for the treatment of cancer is looking compelling, according to a new study published in the Journal of Pineal Research. Researchers say that the results are so compelling that cancer funding agencies should be eager to support clinical trials to evaluate its therapeutic role in a variety of cancers.
Melatonin is a hormone naturally found in humans. Its association with cancer has been shown in many studies assessing links between shift work and cancer rates, and shown a consistent relationship. The association between melatonin levels and cancer progression has suggested to some that melatonin may be a modifier of cancer progression. In this latest study, researchers examined all clinical trials assessing the role of melatonin as a therapy for solid tumor cancers. They used a methodology called meta-analysis, a technique of analyzing multiple studies.
The authors reviewed 10 randomized clinical trials that included a total of 643 cancer patients with a variety of different solid tumor cancers. The types of cancers involved included lung, brain, skin, renal and breast cancer. "In this analysis, the effects appeared to be consistent across studies" say the authors. The researchers examined the effect of large doses of melatonin (10-40mg/day) on survival rates at one year. Melatonin reduced the risk of death at one year by 34%. "Effects this large certainly warrant further clinical trials" say the authors. The study also showed that melatonin was predominantly safe and had a beneficial effect on sleep patterns of patients.
He who learns must suffer, and, even in our sleep, pain that cannot forget falls drop by drop upon the heart, and in our own despair, against our will, comes wisdom to us by the awful grace of God.
- Aeschylus
”
Recent Comments
Years ago I read Gregg Braden's book, The God Code. I do not remember the whole premise, but he had determined that there was a computer-type code...